HMGB1 and autoimmune polyendocrinopathy: In APS patients with recurrent thrombosis, a tendency to have elevated HMGB1 serum levels has been highlighted, compared to APS patients without recurrent thrombosis, although this result does not reach statistical significance (Table 2).